Smith Michael Eric's Form 4 filing
Danimer Scientific, Inc. (DNMR) · filed Sep 20, 2021
- Accession no.
- 0001213900-21-048937
- Filed
- Sep 20, 2021
- Trade date
- Sep 17, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $166.2K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Michael EricCIK 0001836650 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | Class A Common Stock ("Common Stock") | MOption exerciseAcquired | +10,000 | $3.28 | +$32,800 | 387,259 | Direct | |
| Sep 17, 2021 | Common Stock | SSaleDisposed | −10,000 | $16.62F3 | −$166,200 | 377,259 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 658,909 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The August 17, 2021 sale of 10,000 shares of Common Stock was executed in multiple trades at prices ranging from $16.56 to $16.68. The price reported above reflects the volume-weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.